Meropenem
Form: Intravenous (IV) Injection
Strength: 500 mg/vial, 1 g/vial
Reference Brands: Merrem IV(US)
Category: Critical Care
Meropenem is a broad-spectrum carbapenem antibiotic used to treat severe bacterial infections, including pneumonia, intra-abdominal infections, meningitis, and sepsis. It is administered intravenously and is available as a lyophilized powder in 500 mg and 1 g vials, as well as ready-to-use infusions. In the US, Meropenem is marketed as Merrem IV (Pfizer) and distributed by Sagent, Fresenius, and Hikma. In the EU, it is available under the brand Meronem and from Accord, Kabi, and Mylan. Hospitals and ICUs frequently procure Meropenem through pharma B2B platforms for its efficacy against multidrug-resistant gram-negative and gram-positive bacteria.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Glucagon
Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)
Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection
Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)
View Details Get Enquiry
Insulin (IV)
Strength: 100 units/mL (U-100) in 10 mL vials
Form: Intravenous (IV) solution
Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)
View Details Get Enquiry
Flumazenil
Strength: 0.1 mg/mL in 5 mL or 10 mL vials
Form: Intravenous (IV) injection
Reference Brands: Romazicon®(US), Anexate®(EU)
View Details Get Enquiry
Naloxone
Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes
Form: Intravenous (IV) injection/IM/SQ
Reference Brands: Narcan® (US); Narcan® (EU)
View Details Get Enquiry